Xyntek Incorporated, a world leader in pharmaceutical and life sciences automation and IT solutions, has signed a partnership agreement with Nymi to increase their Turnkey Biometrics Authentication Platform to incorporate wearable technology.
Nymi Bands join an impressive list of iris and fingerprint scanning technologies that Xyntek integrates into business-critical operations and processes. These solutions bring significant improvements and efficiencies to complex and GxP controlled laboratory, manufacturing and healthcare processes that require user authentication and electronic signatures to review and approve completion of critical process steps.
Nymi鈥檚 unique wearable authentication solution, activated by a user鈥檚 biometrics, keeps workers continuously authenticated to facilitate rapid logins / e-signatures with a tap of the wrist.
鈥淚n the past, a user鈥檚 identity was verified based on what we know, such as our username, passwords, and PINs, or what we have, such as ID and access cards,鈥� said Mac Hashemian, PE, CEO of Xyntek.
鈥淏iometric authentication enables user identification based on who we are by using unique physical characteristics like iris patterns and fingerprints to allow access to extremely sensitive systems, information and / or environments. With digital transformation and the push for mobility, we now have to factor in 鈥榳hat extends us鈥� to this equation. The Nymi Biometric wearable technology offers an additional level of flexibility that provides operators with a more efficient way to achieve compliance and security without compromising productivity.鈥�
Xyntek鈥檚 platform is built around a high-availability centralised authentication service, which transforms a user鈥檚 biometric identity into their enterprise account credentials in seconds. Xyntek鈥檚 platform supports all standard biometric devices, including fingerprints and iris scanners. This new partnership will add wearable technology, Nymi bands, to the platform.
鈥淲e are excited to be working closely with Xyntek and integrating the Nymi bands into Xyntek鈥檚 portfolio of solutions and services,鈥� said Nymi鈥檚 Vice President, Andrew Foxcroft.
鈥淭here are many use cases in the Life Sciences GxP environments that can benefit from wearable authentication devices. By combining our technology with Xyntek鈥檚 Biometric Authentication Platform, we can address a number of important use cases featuring enterprise authentication that delivers data integrity and security, allowing highly regulated industries to achieve compliance and productivity.鈥� Mac Hashemian, CEO of Xyntek, and Nymi鈥檚 Vice President, Andrew Foxcroft, are available for interviews.
High-resolution images are available upon request. Just聽fill out the enquiry form attached to this page for more information.